🔎 Trials Near Me

Home › Schizophrenia › Georgia › Atlanta

Schizophrenia clinical trials in Atlanta, GA

22 studies for Schizophrenia are looking for participants at sites in and around Atlanta (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

RecruitingPhase 4
  • Vanda Investigational Site, Atlanta
  • Vanda Investigational Site, Atlanta
  • Vanda Investigational Site, Decatur · 6 mi away
Ages 12 to 17 · All sexes · Updated Oct 1, 2026 · NCT05648591

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

RecruitingPhase 1
  • Synexus Clinical Research US Inc, Atlanta
Ages 18 to 55 · All sexes · Updated Sep 28, 2026 · NCT07615426

Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia

RecruitingPhase 3
  • Atlanta Center for Medical Research, Atlanta
Ages 18 to 65 · All sexes · Updated Sep 28, 2026 · NCT07686263

Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder

RecruitingPhase 3
  • CenExeli Research LLC, Atlanta
  • Atlanta Center for Medical Research, Atlanta
Ages 5 to 17 · All sexes · Updated Sep 25, 2026 · NCT06229210

NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia

RecruitingPhase 3
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Decatur · 6 mi away
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07114874

Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia

RecruitingPhase 3
  • Neurocrine Clinical Site, Atlanta
Ages 18 to 65 · All sexes · Updated Sep 25, 2026 · NCT07227818

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

RecruitingPhase 3
  • Atlanta Center for Medical Research, Atlanta
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi away
Ages 5 to 17 · All sexes · Updated Sep 22, 2026 · NCT07424404

A Study of Brenipatide in Adult Participants With Schizophrenia

RecruitingPhase 2
  • Atlanta Center for Medical Research, Atlanta
Ages 18 to 55 · All sexes · Updated Sep 22, 2026 · NCT07410507

A Study of LTX-001 In Adult Participants With Acute Exacerbation of Schizophrenia

RecruitingPhase 1
  • CenExel iResearch, LLC, Decatur · 6 mi away
Ages 18 to 55 · All sexes · Updated Sep 17, 2026 · NCT07734493

52-week Open Label Safety-Tolerability Study

RecruitingPhase 3
  • CenExel, Atlanta
Ages 18 to 65 · All sexes · Updated Sep 9, 2026 · NCT07369154

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)

RecruitingPhase 3
  • Atlanta Center for Medical Research, Atlanta
  • Denali Health Atlanta, LLC, Stone Mountain · 13 mi away
Ages 13 to 17 · All sexes · Updated Sep 4, 2026 · NCT07288567

A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT

RecruitingPhase 1
  • Atlanta Center for Medical Research, Atlanta
  • CenExel iResearch, LLC, Decatur · 6 mi away
Ages 18 to 55 · All sexes · Updated Sep 2, 2026 · NCT07061288

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

RecruitingPhase 2
  • Clinical Site, Atlanta
  • Clinical Site, Decatur · 6 mi away
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07459647

Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)

RecruitingObservational study
  • Emory University., Atlanta
  • Local Institution - 0049, Austell · 15 mi away
Ages 18 and older · All sexes · Updated Aug 19, 2026 · NCT07379827

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

RecruitingPhase 3
  • Alkermes Investigator Site, Decatur · 6 mi away
Ages 10 to 17 · All sexes · Updated Aug 14, 2026 · NCT05303064

Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder

RecruitingPhase 1
  • Bioxcel Clinical Research Site, Decatur · 6 mi away
Ages 10 to 17 · All sexes · Updated Aug 11, 2026 · NCT05025605

Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia

RecruitingPhase 2
  • CenExel iResearch, Decatur · 6 mi away
Ages 18 to 65 · All sexes · Updated Jul 29, 2026 · NCT07467993

A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

RecruitingPhase 2
  • Cenexel ACMR, Atlanta
  • Cenexel iResearch Atlanta, Decatur · 6 mi away
Ages 18 to 55 · All sexes · Updated Jun 23, 2026 · NCT07191483

Anti-Inflammatory Challenge in Schizophrenia

RecruitingPhase 4
  • Grady Memorial Hospital, Atlanta
  • Emory University Hospital, Atlanta
Ages 18 to 55 · All sexes · Updated Jun 3, 2026 · NCT05823532

NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia

RecruitingPhase 3
  • Neurocrine Clinical Site, Atlanta
  • Neurocrine Clinical Site, Decatur · 6 mi away
Ages 18 to 65 · All sexes · Updated Mar 6, 2026 · NCT06963034

Randomized Withdrawal Study in Patients With Schizophrenia

RecruitingPhase 3
  • Vanda Investigational Site, Atlanta
Ages 18 to 65 · All sexes · Updated Jan 12, 2026 · NCT06961968

Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

RecruitingPhase 3Healthy volunteers welcome
  • Reviva site, Atlanta
  • Reviva site, Decatur · 6 mi away
Ages 18 to 65 · All sexes · Updated Dec 19, 2024 · NCT05184335

About Schizophrenia

Schizophrenia is a serious brain illness that can include hearing voices that aren't there and thinking others are trying to hurt them.

More about Schizophrenia on MedlinePlus

Schizophrenia trials in other cities

Other studies in Atlanta

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.